Axogen Inc vs Cassava Sciences Inc — how do they compare? Axogen Inc trades at $48.21 (market cap $2.61B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Axogen Inc is far larger — about 54.7× Cassava Sciences Inc's market cap, and Axogen Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| AXGN | FLNA | |
|---|---|---|
Market Cap | $2.61B | $47.75M |
Sector | Technology | Health |
52-Week High | $48.48 | $4.64 |
52-Week Low | $14.16 | $0.87 |
Enterprise Value | $2.52B | -$34.93M |
Trailing returns across standard periods
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →